Global Vaccine Market Outlook (2007-2010)

1.   Analyst View

2.   Research Overview

3.   Vaccines - An Introduction
         3.1   History
         3.2   Vaccine Production Stages
                   3.2.1   Cultivation
                   3.2.2   Purification
                   3.2.3   Quality Control
                   3.2.4   Packaging
         3.3   Vaccine Approval Process
                   3.3.1   Phase I
                   3.3.2   Phase II
                   3.3.3   Phase III
                   3.3.4   Phase IV
         3.4   Regulatory Frameworks & Intellectual Property Rights
                   3.4.1   Product Equals Process
                   3.4.2   Regulatory Requirements
                   3.4.3   Patent Protections
         3.5   Types of Vaccine
                   3.5.1   Live Attenuated Vaccines
                   3.5.2   Killed Vaccines
                   3.5.3   Toxoid Vaccines
                   3.5.4   Component Vaccines
                   3.5.5   Genetically Engineered Vaccines
                   3.5.6   DNA Vaccines

4.   Market Analysis
         4.1   Global Vaccine Market

5.   Industry Performance
         5.1   Key Geographical Markets
                   5.1.1   US
                   5.1.2   Europe
                   5.1.3   Japan
                   5.1.4   China
                   5.1.5   India
                   5.1.6   Brazil
         5.2   Major Vaccine Segments
                   5.2.1   Basic Pediatrics
                   5.2.2   Enhanced Pediatrics
                   5.2.3   Proprietary Pediatrics
                   5.2.4   Adult/Travel
                   5.2.5   Therapeutics
                              5.2.5.1   Cancer Vaccines
                              5.2.5.2   Addiction Vaccines
                  5.2.6   Influenza

6.   Major Pediatric Vaccines
         6.1   Pneumococcal Vaccines
         6.2   Polio Vaccines
         6.3   Varicella Vaccines
         6.4   Meningitis Vaccines
         6.5   Rotavirus Vaccines
         6.6   DTP Vaccines
         6.7   Measles, Mumps & Rubella (MMR) Vaccines
         6.8   Tuberculosis Vaccines

7.   Major Adult/Travel & Therapeutic Vaccines
         7.1   Hepatitis B Vaccines
         7.2   Malaria Vaccines
         7.3   Japanese Encephalitis Vaccines
         7.4   Ebola Vaccines
         7.5   Cervical Cancer Vaccines
         7.6   Typhoid Vaccines
         7.7   West Nile Vaccines
         7.8   HIV Vaccines

8.   Industry Analysis
         8.1   Market Drivers
                   8.1.1   Diseases Prevention
                   8.1.2   Higher Margins
                   8.1.3   Increased Funding from Government & NGOs
                   8.1.4   Government Regulations
                   8.1.5   Blockbuster Potential of New Vaccines
                   8.1.6   Increasing Population in Developing Countries
                   8.1.7   Disease Awareness
         8.2   Opportunities
                   8.2.1   Contract Research
                   8.2.2   Influenza Vaccine Segment
                   8.2.3   India & China - Future Hub for Pediatric Vaccine Manufacturing
                   8.2.4   Cancer Vaccine Segment
                   8.2.5   Addiction Vaccine Segment
         8.3   Challenges
                   8.3.1   Huge R&D Cost
                   8.3.2   Lack of Infrastructure for Trials & Manufactures
                   8.3.3   Effective Vaccine Design
                   8.3.4   Vaccine Supply
                   8.3.5   Immunization Safety

9.   Vaccine Market Players
         9.1   Major Categories
                   9.1.1   Vaccine Majors
                   9.1.2   Vaccine-focused Biotech Companies
                   9.1.3   Domestic-focused Vaccine Companies
         9.2   Key Players
                   9.2.1   Sanofi-Aventis
                   9.2.2   GlaxoSmithKline Plc.
                   9.2.3   Merck & Co., Inc.
                   9.2.4   Novartis
                   9.2.5   Wyeth